Analytical Lens: Exploring Travere Therapeutics Inc (TVTX)’s Financial Story Through Ratios

Beyond market averages, investors looking for exceptional returns turn to stock picking. Skillful choices in individual stocks have the power to substantially increase your wealth.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

The closing price of Travere Therapeutics Inc (NASDAQ: TVTX) was $17.69 for the day, up 1.43% from the previous closing price of $17.44. In other words, the price has increased by $1.43 from its previous closing price. On the day, 1.66 million shares were traded. TVTX stock price reached its highest trading level at $17.775 during the session, while it also had its lowest trading level at $17.02.

Ratios:

Our analysis of TVTX’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 2.99 and its Current Ratio is at 3.04. In the meantime, Its Debt-to-Equity ratio is 26.62 whereas as Long-Term Debt/Eq ratio is at 26.27.

Citigroup Upgraded its Neutral to Buy on December 05, 2023, whereas the target price for the stock was revised from $7 to $10.

Insider Transactions:

Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Oct 04 ’24 when LYONS GARY A sold 40,000 shares for $14.73 per share. The transaction valued at 589,101 led to the insider holds 51,000 shares of the business.

GARY A LYONS bought 40,000 shares of TVTX for $546,000 on Oct 04 ’24. On Sep 30 ’24, another insider, Meckler Jeffrey A, who serves as the Director of the company, sold 40,000 shares for $14.06 each. As a result, the insider received 562,324 and left with 81,000 shares of the company.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, TVTX now has a Market Capitalization of 1353134720 and an Enterprise Value of 1430964352. For the stock, the TTM Price-to-Sale (P/S) ratio is 7.62 while its Price-to-Book (P/B) ratio in mrq is 89.29. Its current Enterprise Value per Revenue stands at 8.055 whereas that against EBITDA is -5.202.

Stock Price History:

Over the past 52 weeks, TVTX has reached a high of $18.60, while it has fallen to a 52-week low of $5.12. The 50-Day Moving Average of the stock is 45.95%, while the 200-Day Moving Average is calculated to be 97.85%.

Shares Statistics:

TVTX traded an average of 1.75M shares per day over the past three months and 3117880 shares per day over the past ten days. A total of 75.37M shares are outstanding, with a floating share count of 75.34M. Insiders hold about 1.51% of the company’s shares, while institutions hold 117.50% stake in the company. Shares short for TVTX as of 1727654400 were 6962090 with a Short Ratio of 3.98, compared to 1724976000 on 9253644. Therefore, it implies a Short% of Shares Outstanding of 6962090 and a Short% of Float of 10.24.

Most Popular